JPWO2020232545A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020232545A5
JPWO2020232545A5 JP2022516247A JP2022516247A JPWO2020232545A5 JP WO2020232545 A5 JPWO2020232545 A5 JP WO2020232545A5 JP 2022516247 A JP2022516247 A JP 2022516247A JP 2022516247 A JP2022516247 A JP 2022516247A JP WO2020232545 A5 JPWO2020232545 A5 JP WO2020232545A5
Authority
JP
Japan
Prior art keywords
group
alkyl
alkynyl
alkenyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022516247A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022533484A5 (https=
JP7654642B2 (ja
JP2022533484A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/050674 external-priority patent/WO2020232545A1/en
Publication of JP2022533484A publication Critical patent/JP2022533484A/ja
Publication of JP2022533484A5 publication Critical patent/JP2022533484A5/ja
Publication of JPWO2020232545A5 publication Critical patent/JPWO2020232545A5/ja
Application granted granted Critical
Publication of JP7654642B2 publication Critical patent/JP7654642B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022516247A 2019-05-23 2020-05-20 触媒によるカンナビノイドプロセスおよび前駆体 Active JP7654642B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962851837P 2019-05-23 2019-05-23
US62/851,837 2019-05-23
US201962890661P 2019-08-23 2019-08-23
US62/890,661 2019-08-23
PCT/CA2020/050674 WO2020232545A1 (en) 2019-05-23 2020-05-20 Catalytic cannabinoid processes and precursors

Publications (4)

Publication Number Publication Date
JP2022533484A JP2022533484A (ja) 2022-07-22
JP2022533484A5 JP2022533484A5 (https=) 2023-05-23
JPWO2020232545A5 true JPWO2020232545A5 (https=) 2023-05-23
JP7654642B2 JP7654642B2 (ja) 2025-04-01

Family

ID=73459164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022516247A Active JP7654642B2 (ja) 2019-05-23 2020-05-20 触媒によるカンナビノイドプロセスおよび前駆体

Country Status (11)

Country Link
US (1) US20220220089A1 (https=)
EP (1) EP3959193A4 (https=)
JP (1) JP7654642B2 (https=)
KR (1) KR20220012298A (https=)
CN (1) CN114269717A (https=)
AU (1) AU2020280231A1 (https=)
CA (3) CA3179248C (https=)
IL (1) IL288196B2 (https=)
MX (1) MX2021014329A (https=)
SG (1) SG11202112677WA (https=)
WO (1) WO2020232545A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201916849D0 (en) 2019-11-19 2020-01-01 Gw Res Ltd Cannabidiol-type cannabinoid compound
BR112022019616A2 (pt) * 2020-03-31 2022-12-06 Phytotherapeutix Ltd Compostos terpenofenólicos e seu uso
CA3174197A1 (en) * 2020-03-31 2021-10-07 Kamaluddin Abdur-Rashid Catalytic cannabigerol processes and precursors
US20230192588A1 (en) * 2020-06-03 2023-06-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cannabidiolic acid (cbda) derivatives and uses thereof
EP4253390A4 (en) * 2020-11-25 2024-12-04 Chengdu Baiyu Pharmaceutical Co., Ltd. PROCESS FOR PURIFYING CANNABINOID COMPOUNDS
GB2602019A (en) 2020-12-15 2022-06-22 Gw Res Ltd Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof
WO2022133544A1 (en) * 2020-12-23 2022-06-30 Botanix Pharmaceuticals Limited Cbd cannabinoids and cbd cannabinoid analogues
TW202304857A (zh) * 2021-04-07 2023-02-01 加拿大商美蒂普爾製藥公司 內生性大麻素系統靶向前驅藥及其治療用途
ES3058168T3 (en) * 2021-05-12 2026-03-09 Jazz Pharmaceuticals Research Uk Ltd Resorcinol derivative as a pharmaceutically active compound and method of preparation thereof
WO2023004414A1 (en) * 2021-07-23 2023-01-26 Colorado Chromatography, Llc A method for preparing hexahydrocannabinol
AU2022324615A1 (en) 2021-08-04 2024-02-15 Demeetra Agbio, Inc. Cannabinoid derivatives and their use
AU2022403631A1 (en) * 2021-12-09 2024-07-25 Kare Chemical Technologies Inc. Catalytic tetrahydrocannabinol synthesis and precursors
US20260097049A1 (en) * 2022-09-29 2026-04-09 Blackstone Therapeutics, Llc Cannabinoid analogs and methods of use for treatment and prevention of cancer
AU2023404746A1 (en) * 2022-12-02 2025-07-17 Benethera (Shaoxing) Biotechnology Co., Ltd. Compound and use thereof in treatment of treg-related diseases
WO2025006693A1 (en) * 2023-06-30 2025-01-02 University Of Mississippi Cannabidiol-like compounds and methods for the selective preparation of the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI366460B (en) * 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
CN102766128A (zh) * 2005-09-29 2012-11-07 阿尔巴尼分子研究公司 δ-9-四氢大麻酚的生成方法
JP5704925B2 (ja) 2008-02-08 2015-04-22 ウェルズ ファーゴ バンク ナショナル アソシエイション オリゴマー−カンナビノイドコンジュゲート
US20120172339A1 (en) * 2009-07-10 2012-07-05 Northeastern University Angiogenic resorcinol derivatives
US20180037528A1 (en) 2015-02-27 2018-02-08 The Feinstein Institute For Medical Research Treatment method, compounds, and method of increasing trpv2 activity
US20170008869A1 (en) * 2015-07-10 2017-01-12 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
DK3455213T3 (da) * 2016-05-13 2022-03-07 Symrise Ag Fremgangsmåde til at oprense cannabinoid-forbindelser via simulated moving bed-kromatografi
WO2020069214A2 (en) * 2018-09-26 2020-04-02 Demetrix, Inc. Optimized expression systems for producing cannabinoid synthase polypeptides, cannabinoids, and cannabinoid derivatives
CN112062697B (zh) 2019-05-22 2023-09-01 上海特化医药科技有限公司 间苯多酚衍生物及其制备方法
CN114981235A (zh) * 2019-09-09 2022-08-30 卡瑞化学技术公司 大麻素衍生物、前体和用途
BR112022019616A2 (pt) * 2020-03-31 2022-12-06 Phytotherapeutix Ltd Compostos terpenofenólicos e seu uso

Similar Documents

Publication Publication Date Title
JPWO2020232545A5 (https=)
JP2022023958A5 (https=)
JP4166218B2 (ja) アミノ−プロパノール誘導体
DE69806035T2 (de) Neue vitamin d-analoga
US6043236A (en) Estrogens
JP2015500210A (ja) (3r)−2,4−ジ−脱離基−3−メチルブタ−1−エンの調製方法
JP2018500336A5 (https=)
DE3016054A1 (de) Prostacyclin-analoge und ihre verwendung
JPH0717595B2 (ja) フエノ−ル誘導体、その製造法、および該化合物を含有する抗エストロゲン作用を有する医薬組成物
JPWO2023003014A5 (https=)
HUT62560A (en) Process for producing 24-oxa derivatives belonging to vitamin d series and pharmaceutical compositions comprising same as active ingredient
CZ2006386A3 (cs) Zpusob syntézy prostaglandinu
JPH07508515A (ja) ビタミンd系列の22−エン−25−オキサ−誘導体,該化合物の製造法,該誘導体を含有する薬学的調剤ならびに薬剤としての該調剤の使用
RU2058312C1 (ru) Способ получения имидазо-пиридинов или их кислотно-аддитивных солей и имидазо-пиридины.
CZ194798A3 (cs) Deriváty vitaminu D, způsob výroby a farmaceutický prostředek
JP2006515867A (ja) 鉄含有量が非常に低いリセドロン酸ナトリウム
WO1999064393A1 (de) Neue antiestrogene, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
JPWO2021085535A5 (https=)
JPH05117230A (ja) プロスタグランジン誘導体
WO2000039148A1 (de) Neue 7-alpha, 17-alpha-bis-alkylierte testosteronderivate und ihre verwendung zur langzeittherapie von androgen-abhängigen erkrankungen
JPWO2019152911A5 (https=)
US20050113349A1 (en) 2-Alpha vitamin D derivatives having substituents
US2907765A (en) Piperazine derivatives
MX394408B (es) Proceso para la preparacion y purificacion de misoprostol.
US4617409A (en) Aminomethyltriorganotin compounds, preferably α-mono or disubstituted; and the method of preparation